nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—CYP3A4—Topotecan—ovarian cancer	0.03	0.272	CbGbCtD
Zileuton—CYP2C9—Paclitaxel—ovarian cancer	0.0256	0.232	CbGbCtD
Zileuton—LTB4R—uterine cervix—ovarian cancer	0.0226	0.0874	CbGeAlD
Zileuton—EPHX2—myometrium—ovarian cancer	0.0213	0.0826	CbGeAlD
Zileuton—CYP3A4—Vinorelbine—ovarian cancer	0.0212	0.192	CbGbCtD
Zileuton—PTGS1—oviduct—ovarian cancer	0.016	0.0621	CbGeAlD
Zileuton—LTB4R—bone marrow—ovarian cancer	0.016	0.0618	CbGeAlD
Zileuton—LTB4R—female gonad—ovarian cancer	0.0154	0.0596	CbGeAlD
Zileuton—LTB4R—vagina—ovarian cancer	0.0153	0.0592	CbGeAlD
Zileuton—CYP3A4—Paclitaxel—ovarian cancer	0.0149	0.135	CbGbCtD
Zileuton—EPHX2—uterus—ovarian cancer	0.0138	0.0536	CbGeAlD
Zileuton—LTB4R—testis—ovarian cancer	0.0137	0.0528	CbGeAlD
Zileuton—EPHX2—female gonad—ovarian cancer	0.0113	0.0438	CbGeAlD
Zileuton—EPHX2—vagina—ovarian cancer	0.0113	0.0436	CbGeAlD
Zileuton—Hepatotoxicity—Chlorambucil—ovarian cancer	0.0109	0.0245	CcSEcCtD
Zileuton—Liver disorder—Melphalan—ovarian cancer	0.0108	0.0242	CcSEcCtD
Zileuton—CYP3A4—Docetaxel—ovarian cancer	0.0108	0.0974	CbGbCtD
Zileuton—EPHX2—testis—ovarian cancer	0.01	0.0389	CbGeAlD
Zileuton—LTB4R—lymph node—ovarian cancer	0.0099	0.0383	CbGeAlD
Zileuton—ALOX5—decidua—ovarian cancer	0.00948	0.0367	CbGeAlD
Zileuton—Hyperbilirubinaemia—Topotecan—ovarian cancer	0.00826	0.0185	CcSEcCtD
Zileuton—CYP3A4—Doxorubicin—ovarian cancer	0.00802	0.0726	CbGbCtD
Zileuton—ALOX5—female reproductive system—ovarian cancer	0.00746	0.0289	CbGeAlD
Zileuton—EPHX2—lymph node—ovarian cancer	0.00728	0.0282	CbGeAlD
Zileuton—Lymphadenopathy—Chlorambucil—ovarian cancer	0.00718	0.0161	CcSEcCtD
Zileuton—ALOX5—bone marrow—ovarian cancer	0.00704	0.0272	CbGeAlD
Zileuton—ALOX5—female gonad—ovarian cancer	0.00679	0.0263	CbGeAlD
Zileuton—Pharyngolaryngeal pain—Paclitaxel—ovarian cancer	0.0064	0.0143	CcSEcCtD
Zileuton—Laryngeal pain—Paclitaxel—ovarian cancer	0.00634	0.0142	CcSEcCtD
Zileuton—ALOX5—testis—ovarian cancer	0.00602	0.0233	CbGeAlD
Zileuton—Dizziness—Altretamine—ovarian cancer	0.0056	0.0126	CcSEcCtD
Zileuton—Pharyngolaryngeal pain—Docetaxel—ovarian cancer	0.00542	0.0122	CcSEcCtD
Zileuton—Vomiting—Altretamine—ovarian cancer	0.00538	0.0121	CcSEcCtD
Zileuton—Liver disorder—Docetaxel—ovarian cancer	0.00537	0.012	CcSEcCtD
Zileuton—Laryngeal pain—Docetaxel—ovarian cancer	0.00537	0.012	CcSEcCtD
Zileuton—Nausea—Altretamine—ovarian cancer	0.00503	0.0113	CcSEcCtD
Zileuton—Pain—Carboplatin—ovarian cancer	0.005	0.0112	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Paclitaxel—ovarian cancer	0.00475	0.0107	CcSEcCtD
Zileuton—Hepatotoxicity—Docetaxel—ovarian cancer	0.00474	0.0106	CcSEcCtD
Zileuton—Body temperature increased—Carboplatin—ovarian cancer	0.00462	0.0104	CcSEcCtD
Zileuton—Jaundice—Chlorambucil—ovarian cancer	0.0046	0.0103	CcSEcCtD
Zileuton—Neck pain—Paclitaxel—ovarian cancer	0.00437	0.0098	CcSEcCtD
Zileuton—ALOX5—lymph node—ovarian cancer	0.00436	0.0169	CbGeAlD
Zileuton—PTGS1—epithelium—ovarian cancer	0.00403	0.0156	CbGeAlD
Zileuton—Hyperbilirubinaemia—Docetaxel—ovarian cancer	0.00403	0.00903	CcSEcCtD
Zileuton—Jaundice—Melphalan—ovarian cancer	0.00401	0.00899	CcSEcCtD
Zileuton—PTGS1—uterine cervix—ovarian cancer	0.00399	0.0155	CbGeAlD
Zileuton—Hypertonia—Paclitaxel—ovarian cancer	0.00379	0.00849	CcSEcCtD
Zileuton—Hepatitis—Melphalan—ovarian cancer	0.00369	0.00828	CcSEcCtD
Zileuton—PTGS1—endometrium—ovarian cancer	0.00361	0.014	CbGeAlD
Zileuton—PTGS1—uterus—ovarian cancer	0.00333	0.0129	CbGeAlD
Zileuton—CYP2C9—female reproductive system—ovarian cancer	0.00328	0.0127	CbGeAlD
Zileuton—Ill-defined disorder—Topotecan—ovarian cancer	0.00305	0.00683	CcSEcCtD
Zileuton—PTGS1—female reproductive system—ovarian cancer	0.00299	0.0116	CbGeAlD
Zileuton—Malaise—Topotecan—ovarian cancer	0.00296	0.00664	CcSEcCtD
Zileuton—Liver injury—Epirubicin—ovarian cancer	0.00294	0.00658	CcSEcCtD
Zileuton—Abdominal pain upper—Paclitaxel—ovarian cancer	0.00286	0.00642	CcSEcCtD
Zileuton—Myalgia—Topotecan—ovarian cancer	0.00279	0.00626	CcSEcCtD
Zileuton—Chest pain—Topotecan—ovarian cancer	0.00279	0.00626	CcSEcCtD
Zileuton—Arthralgia—Topotecan—ovarian cancer	0.00279	0.00626	CcSEcCtD
Zileuton—Discomfort—Topotecan—ovarian cancer	0.00276	0.00619	CcSEcCtD
Zileuton—Myalgia—Melphalan—ovarian cancer	0.00274	0.00613	CcSEcCtD
Zileuton—Chest pain—Melphalan—ovarian cancer	0.00274	0.00613	CcSEcCtD
Zileuton—PTGS1—female gonad—ovarian cancer	0.00272	0.0105	CbGeAlD
Zileuton—Hyperbilirubinaemia—Epirubicin—ovarian cancer	0.00272	0.00609	CcSEcCtD
Zileuton—Liver injury—Doxorubicin—ovarian cancer	0.00272	0.00609	CcSEcCtD
Zileuton—PTGS1—vagina—ovarian cancer	0.00271	0.0105	CbGeAlD
Zileuton—Dyspepsia—Chlorambucil—ovarian cancer	0.00265	0.00594	CcSEcCtD
Zileuton—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00261	0.00584	CcSEcCtD
Zileuton—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.0026	0.00582	CcSEcCtD
Zileuton—Pain—Chlorambucil—ovarian cancer	0.00257	0.00577	CcSEcCtD
Zileuton—Malaise—Vinorelbine—ovarian cancer	0.00253	0.00568	CcSEcCtD
Zileuton—Upper respiratory tract infection—Paclitaxel—ovarian cancer	0.00252	0.00565	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Doxorubicin—ovarian cancer	0.00251	0.00563	CcSEcCtD
Zileuton—CYP3A4—female reproductive system—ovarian cancer	0.0025	0.00968	CbGeAlD
Zileuton—Neck pain—Epirubicin—ovarian cancer	0.0025	0.0056	CcSEcCtD
Zileuton—Feeling abnormal—Chlorambucil—ovarian cancer	0.00248	0.00556	CcSEcCtD
Zileuton—Vaginal inflammation—Epirubicin—ovarian cancer	0.00247	0.00554	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00244	0.00547	CcSEcCtD
Zileuton—Abdominal pain upper—Docetaxel—ovarian cancer	0.00243	0.00544	CcSEcCtD
Zileuton—PTGS1—testis—ovarian cancer	0.00242	0.00935	CbGeAlD
Zileuton—Urticaria—Chlorambucil—ovarian cancer	0.00239	0.00536	CcSEcCtD
Zileuton—Arthralgia—Vinorelbine—ovarian cancer	0.00239	0.00536	CcSEcCtD
Zileuton—Myalgia—Vinorelbine—ovarian cancer	0.00239	0.00536	CcSEcCtD
Zileuton—Chest pain—Vinorelbine—ovarian cancer	0.00239	0.00536	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00239	0.00536	CcSEcCtD
Zileuton—Body temperature increased—Chlorambucil—ovarian cancer	0.00238	0.00533	CcSEcCtD
Zileuton—Discomfort—Vinorelbine—ovarian cancer	0.00236	0.00529	CcSEcCtD
Zileuton—Dyspepsia—Topotecan—ovarian cancer	0.00236	0.00529	CcSEcCtD
Zileuton—Conjunctivitis—Paclitaxel—ovarian cancer	0.00235	0.00527	CcSEcCtD
Zileuton—Urinary tract infection—Paclitaxel—ovarian cancer	0.00235	0.00527	CcSEcCtD
Zileuton—Vaginal infection—Epirubicin—ovarian cancer	0.00233	0.00523	CcSEcCtD
Zileuton—Neck pain—Doxorubicin—ovarian cancer	0.00231	0.00519	CcSEcCtD
Zileuton—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00231	0.00518	CcSEcCtD
Zileuton—Dyspepsia—Melphalan—ovarian cancer	0.00231	0.00518	CcSEcCtD
Zileuton—Pain—Topotecan—ovarian cancer	0.00229	0.00514	CcSEcCtD
Zileuton—Constipation—Topotecan—ovarian cancer	0.00229	0.00514	CcSEcCtD
Zileuton—Vaginal inflammation—Doxorubicin—ovarian cancer	0.00229	0.00512	CcSEcCtD
Zileuton—Sinusitis—Paclitaxel—ovarian cancer	0.00227	0.00508	CcSEcCtD
Zileuton—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00226	0.00508	CcSEcCtD
Zileuton—Pain—Melphalan—ovarian cancer	0.00224	0.00503	CcSEcCtD
Zileuton—Hypersensitivity—Chlorambucil—ovarian cancer	0.00222	0.00497	CcSEcCtD
Zileuton—Feeling abnormal—Topotecan—ovarian cancer	0.00221	0.00495	CcSEcCtD
Zileuton—Hypertonia—Epirubicin—ovarian cancer	0.00217	0.00485	CcSEcCtD
Zileuton—Vaginal infection—Doxorubicin—ovarian cancer	0.00216	0.00484	CcSEcCtD
Zileuton—Pruritus—Chlorambucil—ovarian cancer	0.00213	0.00477	CcSEcCtD
Zileuton—Urticaria—Topotecan—ovarian cancer	0.00213	0.00477	CcSEcCtD
Zileuton—Body temperature increased—Topotecan—ovarian cancer	0.00212	0.00475	CcSEcCtD
Zileuton—Lymphadenopathy—Epirubicin—ovarian cancer	0.0021	0.00471	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00209	0.00468	CcSEcCtD
Zileuton—Urticaria—Melphalan—ovarian cancer	0.00208	0.00467	CcSEcCtD
Zileuton—Diarrhoea—Chlorambucil—ovarian cancer	0.00206	0.00462	CcSEcCtD
Zileuton—Hypertonia—Doxorubicin—ovarian cancer	0.002	0.00449	CcSEcCtD
Zileuton—Jaundice—Docetaxel—ovarian cancer	0.002	0.00448	CcSEcCtD
Zileuton—Conjunctivitis—Docetaxel—ovarian cancer	0.00199	0.00446	CcSEcCtD
Zileuton—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00198	0.00444	CcSEcCtD
Zileuton—Hypersensitivity—Topotecan—ovarian cancer	0.00197	0.00442	CcSEcCtD
Zileuton—Pain—Vinorelbine—ovarian cancer	0.00196	0.00439	CcSEcCtD
Zileuton—Constipation—Vinorelbine—ovarian cancer	0.00196	0.00439	CcSEcCtD
Zileuton—Lymphadenopathy—Doxorubicin—ovarian cancer	0.00194	0.00436	CcSEcCtD
Zileuton—Hypersensitivity—Melphalan—ovarian cancer	0.00193	0.00433	CcSEcCtD
Zileuton—Vomiting—Chlorambucil—ovarian cancer	0.00191	0.00429	CcSEcCtD
Zileuton—Pruritus—Topotecan—ovarian cancer	0.0019	0.00425	CcSEcCtD
Zileuton—Feeling abnormal—Vinorelbine—ovarian cancer	0.00189	0.00423	CcSEcCtD
Zileuton—Flatulence—Paclitaxel—ovarian cancer	0.00186	0.00417	CcSEcCtD
Zileuton—Pruritus—Melphalan—ovarian cancer	0.00186	0.00416	CcSEcCtD
Zileuton—Tension—Paclitaxel—ovarian cancer	0.00185	0.00415	CcSEcCtD
Zileuton—Hepatitis—Docetaxel—ovarian cancer	0.00184	0.00412	CcSEcCtD
Zileuton—Nervousness—Paclitaxel—ovarian cancer	0.00183	0.00411	CcSEcCtD
Zileuton—Diarrhoea—Topotecan—ovarian cancer	0.00183	0.00411	CcSEcCtD
Zileuton—Urticaria—Vinorelbine—ovarian cancer	0.00182	0.00408	CcSEcCtD
Zileuton—Body temperature increased—Vinorelbine—ovarian cancer	0.00181	0.00406	CcSEcCtD
Zileuton—Diarrhoea—Melphalan—ovarian cancer	0.00179	0.00402	CcSEcCtD
Zileuton—Nausea—Chlorambucil—ovarian cancer	0.00179	0.00401	CcSEcCtD
Zileuton—Dizziness—Topotecan—ovarian cancer	0.00177	0.00397	CcSEcCtD
Zileuton—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00175	0.00393	CcSEcCtD
Zileuton—PTGS1—lymph node—ovarian cancer	0.00175	0.00678	CbGeAlD
Zileuton—Vomiting—Topotecan—ovarian cancer	0.0017	0.00382	CcSEcCtD
Zileuton—Malaise—Paclitaxel—ovarian cancer	0.0017	0.00382	CcSEcCtD
Zileuton—Rash—Topotecan—ovarian cancer	0.00169	0.00379	CcSEcCtD
Zileuton—Hypersensitivity—Vinorelbine—ovarian cancer	0.00169	0.00378	CcSEcCtD
Zileuton—Dermatitis—Topotecan—ovarian cancer	0.00169	0.00378	CcSEcCtD
Zileuton—Headache—Topotecan—ovarian cancer	0.00168	0.00376	CcSEcCtD
Zileuton—Vomiting—Melphalan—ovarian cancer	0.00167	0.00374	CcSEcCtD
Zileuton—Rash—Melphalan—ovarian cancer	0.00165	0.00371	CcSEcCtD
Zileuton—Dermatitis—Melphalan—ovarian cancer	0.00165	0.0037	CcSEcCtD
Zileuton—Abdominal pain upper—Epirubicin—ovarian cancer	0.00164	0.00367	CcSEcCtD
Zileuton—Pruritus—Vinorelbine—ovarian cancer	0.00162	0.00363	CcSEcCtD
Zileuton—Arthralgia—Paclitaxel—ovarian cancer	0.00161	0.0036	CcSEcCtD
Zileuton—Chest pain—Paclitaxel—ovarian cancer	0.00161	0.0036	CcSEcCtD
Zileuton—Myalgia—Paclitaxel—ovarian cancer	0.00161	0.0036	CcSEcCtD
Zileuton—Nausea—Topotecan—ovarian cancer	0.00159	0.00357	CcSEcCtD
Zileuton—Discomfort—Paclitaxel—ovarian cancer	0.00159	0.00356	CcSEcCtD
Zileuton—Diarrhoea—Vinorelbine—ovarian cancer	0.00157	0.00351	CcSEcCtD
Zileuton—Nausea—Melphalan—ovarian cancer	0.00156	0.00349	CcSEcCtD
Zileuton—Dizziness—Vinorelbine—ovarian cancer	0.00152	0.0034	CcSEcCtD
Zileuton—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00152	0.0034	CcSEcCtD
Zileuton—Vomiting—Vinorelbine—ovarian cancer	0.00146	0.00327	CcSEcCtD
Zileuton—Rash—Vinorelbine—ovarian cancer	0.00144	0.00324	CcSEcCtD
Zileuton—Dermatitis—Vinorelbine—ovarian cancer	0.00144	0.00324	CcSEcCtD
Zileuton—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.00144	0.00323	CcSEcCtD
Zileuton—Headache—Vinorelbine—ovarian cancer	0.00144	0.00322	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.0014	0.00315	CcSEcCtD
Zileuton—Insomnia—Paclitaxel—ovarian cancer	0.00139	0.00313	CcSEcCtD
Zileuton—Somnolence—Paclitaxel—ovarian cancer	0.00137	0.00307	CcSEcCtD
Zileuton—Chest pain—Docetaxel—ovarian cancer	0.00136	0.00306	CcSEcCtD
Zileuton—Myalgia—Docetaxel—ovarian cancer	0.00136	0.00306	CcSEcCtD
Zileuton—Arthralgia—Docetaxel—ovarian cancer	0.00136	0.00306	CcSEcCtD
Zileuton—Nausea—Vinorelbine—ovarian cancer	0.00136	0.00305	CcSEcCtD
Zileuton—Dyspepsia—Paclitaxel—ovarian cancer	0.00136	0.00304	CcSEcCtD
Zileuton—Jaundice—Epirubicin—ovarian cancer	0.00135	0.00302	CcSEcCtD
Zileuton—Conjunctivitis—Epirubicin—ovarian cancer	0.00134	0.00301	CcSEcCtD
Zileuton—Urinary tract infection—Epirubicin—ovarian cancer	0.00134	0.00301	CcSEcCtD
Zileuton—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00133	0.00299	CcSEcCtD
Zileuton—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00133	0.00298	CcSEcCtD
Zileuton—Pain—Paclitaxel—ovarian cancer	0.00132	0.00295	CcSEcCtD
Zileuton—Constipation—Paclitaxel—ovarian cancer	0.00132	0.00295	CcSEcCtD
Zileuton—Sinusitis—Epirubicin—ovarian cancer	0.0013	0.00291	CcSEcCtD
Zileuton—Feeling abnormal—Paclitaxel—ovarian cancer	0.00127	0.00285	CcSEcCtD
Zileuton—Jaundice—Doxorubicin—ovarian cancer	0.00125	0.00279	CcSEcCtD
Zileuton—Conjunctivitis—Doxorubicin—ovarian cancer	0.00124	0.00279	CcSEcCtD
Zileuton—Urinary tract infection—Doxorubicin—ovarian cancer	0.00124	0.00279	CcSEcCtD
Zileuton—Hepatitis—Epirubicin—ovarian cancer	0.00124	0.00278	CcSEcCtD
Zileuton—Urticaria—Paclitaxel—ovarian cancer	0.00122	0.00274	CcSEcCtD
Zileuton—Body temperature increased—Paclitaxel—ovarian cancer	0.00122	0.00273	CcSEcCtD
Zileuton—Sinusitis—Doxorubicin—ovarian cancer	0.0012	0.00269	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00119	0.00267	CcSEcCtD
Zileuton—Insomnia—Docetaxel—ovarian cancer	0.00118	0.00265	CcSEcCtD
Zileuton—Somnolence—Docetaxel—ovarian cancer	0.00116	0.0026	CcSEcCtD
Zileuton—Dyspepsia—Docetaxel—ovarian cancer	0.00115	0.00258	CcSEcCtD
Zileuton—Hepatitis—Doxorubicin—ovarian cancer	0.00115	0.00257	CcSEcCtD
Zileuton—Hypersensitivity—Paclitaxel—ovarian cancer	0.00114	0.00255	CcSEcCtD
Zileuton—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00113	0.00253	CcSEcCtD
Zileuton—Pain—Docetaxel—ovarian cancer	0.00112	0.0025	CcSEcCtD
Zileuton—Constipation—Docetaxel—ovarian cancer	0.00112	0.0025	CcSEcCtD
Zileuton—Pruritus—Paclitaxel—ovarian cancer	0.00109	0.00244	CcSEcCtD
Zileuton—Feeling abnormal—Docetaxel—ovarian cancer	0.00108	0.00241	CcSEcCtD
Zileuton—Flatulence—Epirubicin—ovarian cancer	0.00106	0.00239	CcSEcCtD
Zileuton—Tension—Epirubicin—ovarian cancer	0.00106	0.00238	CcSEcCtD
Zileuton—Diarrhoea—Paclitaxel—ovarian cancer	0.00105	0.00236	CcSEcCtD
Zileuton—Nervousness—Epirubicin—ovarian cancer	0.00105	0.00235	CcSEcCtD
Zileuton—Body temperature increased—Docetaxel—ovarian cancer	0.00103	0.00232	CcSEcCtD
Zileuton—Dizziness—Paclitaxel—ovarian cancer	0.00102	0.00228	CcSEcCtD
Zileuton—Ill-defined disorder—Epirubicin—ovarian cancer	0.001	0.00225	CcSEcCtD
Zileuton—Flatulence—Doxorubicin—ovarian cancer	0.000984	0.00221	CcSEcCtD
Zileuton—Tension—Doxorubicin—ovarian cancer	0.00098	0.0022	CcSEcCtD
Zileuton—Vomiting—Paclitaxel—ovarian cancer	0.00098	0.0022	CcSEcCtD
Zileuton—Malaise—Epirubicin—ovarian cancer	0.000974	0.00218	CcSEcCtD
Zileuton—Rash—Paclitaxel—ovarian cancer	0.000972	0.00218	CcSEcCtD
Zileuton—Dermatitis—Paclitaxel—ovarian cancer	0.000971	0.00218	CcSEcCtD
Zileuton—Nervousness—Doxorubicin—ovarian cancer	0.00097	0.00218	CcSEcCtD
Zileuton—Headache—Paclitaxel—ovarian cancer	0.000966	0.00216	CcSEcCtD
Zileuton—Hypersensitivity—Docetaxel—ovarian cancer	0.000963	0.00216	CcSEcCtD
Zileuton—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000927	0.00208	CcSEcCtD
Zileuton—Pruritus—Docetaxel—ovarian cancer	0.000924	0.00207	CcSEcCtD
Zileuton—Chest pain—Epirubicin—ovarian cancer	0.000919	0.00206	CcSEcCtD
Zileuton—Myalgia—Epirubicin—ovarian cancer	0.000919	0.00206	CcSEcCtD
Zileuton—Arthralgia—Epirubicin—ovarian cancer	0.000919	0.00206	CcSEcCtD
Zileuton—Nausea—Paclitaxel—ovarian cancer	0.000916	0.00205	CcSEcCtD
Zileuton—Discomfort—Epirubicin—ovarian cancer	0.000908	0.00204	CcSEcCtD
Zileuton—Malaise—Doxorubicin—ovarian cancer	0.000901	0.00202	CcSEcCtD
Zileuton—Diarrhoea—Docetaxel—ovarian cancer	0.000894	0.002	CcSEcCtD
Zileuton—Dizziness—Docetaxel—ovarian cancer	0.000864	0.00194	CcSEcCtD
Zileuton—Chest pain—Doxorubicin—ovarian cancer	0.000851	0.00191	CcSEcCtD
Zileuton—Myalgia—Doxorubicin—ovarian cancer	0.000851	0.00191	CcSEcCtD
Zileuton—Arthralgia—Doxorubicin—ovarian cancer	0.000851	0.00191	CcSEcCtD
Zileuton—Discomfort—Doxorubicin—ovarian cancer	0.00084	0.00188	CcSEcCtD
Zileuton—Vomiting—Docetaxel—ovarian cancer	0.000831	0.00186	CcSEcCtD
Zileuton—Rash—Docetaxel—ovarian cancer	0.000824	0.00185	CcSEcCtD
Zileuton—Dermatitis—Docetaxel—ovarian cancer	0.000823	0.00184	CcSEcCtD
Zileuton—Headache—Docetaxel—ovarian cancer	0.000818	0.00183	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000803	0.0018	CcSEcCtD
Zileuton—Insomnia—Epirubicin—ovarian cancer	0.000797	0.00179	CcSEcCtD
Zileuton—Somnolence—Epirubicin—ovarian cancer	0.000783	0.00176	CcSEcCtD
Zileuton—Nausea—Docetaxel—ovarian cancer	0.000776	0.00174	CcSEcCtD
Zileuton—Dyspepsia—Epirubicin—ovarian cancer	0.000776	0.00174	CcSEcCtD
Zileuton—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000761	0.00171	CcSEcCtD
Zileuton—Pain—Epirubicin—ovarian cancer	0.000754	0.00169	CcSEcCtD
Zileuton—Constipation—Epirubicin—ovarian cancer	0.000754	0.00169	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000743	0.00167	CcSEcCtD
Zileuton—Insomnia—Doxorubicin—ovarian cancer	0.000737	0.00165	CcSEcCtD
Zileuton—Feeling abnormal—Epirubicin—ovarian cancer	0.000726	0.00163	CcSEcCtD
Zileuton—Somnolence—Doxorubicin—ovarian cancer	0.000725	0.00162	CcSEcCtD
Zileuton—Dyspepsia—Doxorubicin—ovarian cancer	0.000718	0.00161	CcSEcCtD
Zileuton—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000704	0.00158	CcSEcCtD
Zileuton—Urticaria—Epirubicin—ovarian cancer	0.0007	0.00157	CcSEcCtD
Zileuton—Pain—Doxorubicin—ovarian cancer	0.000697	0.00156	CcSEcCtD
Zileuton—Constipation—Doxorubicin—ovarian cancer	0.000697	0.00156	CcSEcCtD
Zileuton—Body temperature increased—Epirubicin—ovarian cancer	0.000697	0.00156	CcSEcCtD
Zileuton—Feeling abnormal—Doxorubicin—ovarian cancer	0.000672	0.00151	CcSEcCtD
Zileuton—Hypersensitivity—Epirubicin—ovarian cancer	0.000649	0.00146	CcSEcCtD
Zileuton—Urticaria—Doxorubicin—ovarian cancer	0.000648	0.00145	CcSEcCtD
Zileuton—Body temperature increased—Doxorubicin—ovarian cancer	0.000645	0.00144	CcSEcCtD
Zileuton—Pruritus—Epirubicin—ovarian cancer	0.000623	0.0014	CcSEcCtD
Zileuton—Diarrhoea—Epirubicin—ovarian cancer	0.000603	0.00135	CcSEcCtD
Zileuton—Hypersensitivity—Doxorubicin—ovarian cancer	0.000601	0.00135	CcSEcCtD
Zileuton—Dizziness—Epirubicin—ovarian cancer	0.000583	0.00131	CcSEcCtD
Zileuton—Pruritus—Doxorubicin—ovarian cancer	0.000577	0.00129	CcSEcCtD
Zileuton—Vomiting—Epirubicin—ovarian cancer	0.00056	0.00126	CcSEcCtD
Zileuton—Diarrhoea—Doxorubicin—ovarian cancer	0.000558	0.00125	CcSEcCtD
Zileuton—Rash—Epirubicin—ovarian cancer	0.000556	0.00125	CcSEcCtD
Zileuton—Dermatitis—Epirubicin—ovarian cancer	0.000555	0.00124	CcSEcCtD
Zileuton—Headache—Epirubicin—ovarian cancer	0.000552	0.00124	CcSEcCtD
Zileuton—Dizziness—Doxorubicin—ovarian cancer	0.000539	0.00121	CcSEcCtD
Zileuton—Nausea—Epirubicin—ovarian cancer	0.000523	0.00117	CcSEcCtD
Zileuton—Vomiting—Doxorubicin—ovarian cancer	0.000518	0.00116	CcSEcCtD
Zileuton—Rash—Doxorubicin—ovarian cancer	0.000514	0.00115	CcSEcCtD
Zileuton—Dermatitis—Doxorubicin—ovarian cancer	0.000514	0.00115	CcSEcCtD
Zileuton—Headache—Doxorubicin—ovarian cancer	0.000511	0.00115	CcSEcCtD
Zileuton—Nausea—Doxorubicin—ovarian cancer	0.000484	0.00109	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—XIAP—ovarian cancer	0.000371	0.002	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—FASN—ovarian cancer	0.000369	0.00199	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000365	0.00197	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—SLC5A5—ovarian cancer	0.000363	0.00196	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SMARCA4—ovarian cancer	0.000361	0.00195	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—NME2—ovarian cancer	0.000354	0.00191	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—EREG—ovarian cancer	0.000353	0.0019	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—SLC2A1—ovarian cancer	0.00035	0.00189	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000343	0.00185	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—CYP1B1—ovarian cancer	0.000336	0.00181	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PGR—ovarian cancer	0.00033	0.00178	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000311	0.00168	CbGpPWpGaD
Zileuton—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000309	0.00167	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PARP1—ovarian cancer	0.000307	0.00166	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000301	0.00162	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PPP2R1A—ovarian cancer	0.000298	0.00161	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000296	0.0016	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL6ST—ovarian cancer	0.000294	0.00159	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—NME2—ovarian cancer	0.000289	0.00156	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PIK3CG—ovarian cancer	0.000282	0.00153	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—ABCB1—ovarian cancer	0.000277	0.00149	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000273	0.00148	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000273	0.00148	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—TYMS—ovarian cancer	0.000272	0.00147	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000261	0.00141	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000261	0.00141	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.000255	0.00138	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—YAP1—ovarian cancer	0.000252	0.00136	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PPP2R1A—ovarian cancer	0.000249	0.00135	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	0.000249	0.00135	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000249	0.00135	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PIK3CD—ovarian cancer	0.000248	0.00134	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000246	0.00133	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000245	0.00132	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000245	0.00132	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000238	0.00129	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCL8—ovarian cancer	0.000229	0.00124	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CYTB—ovarian cancer	0.000228	0.00123	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000223	0.00121	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000219	0.00118	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—CAV1—ovarian cancer	0.000219	0.00118	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—IL2—ovarian cancer	0.000219	0.00118	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000217	0.00117	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PIK3CB—ovarian cancer	0.000216	0.00117	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000214	0.00116	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.000213	0.00115	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00021	0.00113	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000209	0.00113	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCL8—ovarian cancer	0.000208	0.00112	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—FASN—ovarian cancer	0.000205	0.00111	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—SLC5A5—ovarian cancer	0.000202	0.00109	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.0002	0.00108	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.0002	0.00108	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—BRIP1—ovarian cancer	0.0002	0.00108	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PPP1CC—ovarian cancer	0.0002	0.00108	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CG—ovarian cancer	0.000199	0.00108	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IL6—ovarian cancer	0.000199	0.00107	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL2—ovarian cancer	0.000199	0.00107	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TERT—ovarian cancer	0.000198	0.00107	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000195	0.00106	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000195	0.00106	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000195	0.00106	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—SLC2A1—ovarian cancer	0.000195	0.00105	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000192	0.00104	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000191	0.00103	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CYP1B1—ovarian cancer	0.000187	0.00101	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYTB—ovarian cancer	0.000186	0.00101	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000184	0.000997	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CAV1—ovarian cancer	0.000183	0.000989	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000182	0.000983	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ESR1—ovarian cancer	0.000176	0.000953	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CD—ovarian cancer	0.000175	0.000947	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL6ST—ovarian cancer	0.000174	0.000938	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—APC—ovarian cancer	0.000167	0.000901	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CG—ovarian cancer	0.000167	0.000901	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—NRAS—ovarian cancer	0.000167	0.000901	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PPP2R1A—ovarian cancer	0.000166	0.000895	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000165	0.000891	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000164	0.000887	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000164	0.000887	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PPP1CC—ovarian cancer	0.000163	0.000879	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—BRIP1—ovarian cancer	0.000163	0.000879	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000162	0.000875	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—MAPK3—ovarian cancer	0.00016	0.000863	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000157	0.000847	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ABCB1—ovarian cancer	0.000154	0.000831	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CB—ovarian cancer	0.000153	0.000826	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—MAPK1—ovarian cancer	0.000152	0.000821	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—EGFR—ovarian cancer	0.000152	0.000821	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NME2—ovarian cancer	0.000152	0.00082	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—TYMS—ovarian cancer	0.000151	0.000817	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CD—ovarian cancer	0.000147	0.000792	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000145	0.000786	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000145	0.000784	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—KRAS—ovarian cancer	0.000144	0.000775	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—YAP1—ovarian cancer	0.000134	0.000723	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000132	0.000716	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PTEN—ovarian cancer	0.000132	0.000713	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PIK3CA—ovarian cancer	0.000132	0.000712	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NME2—ovarian cancer	0.00013	0.000701	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ERBB2—ovarian cancer	0.000129	0.000699	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000129	0.000696	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CB—ovarian cancer	0.000128	0.00069	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MTOR—ovarian cancer	0.000128	0.00069	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCL8—ovarian cancer	0.000123	0.000663	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—HRAS—ovarian cancer	0.000122	0.000659	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CAV1—ovarian cancer	0.000122	0.000658	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CDKN1B—ovarian cancer	0.00012	0.000648	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—AKT1—ovarian cancer	0.000119	0.000641	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000119	0.000641	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CASP3—ovarian cancer	0.000118	0.000635	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL2—ovarian cancer	0.000117	0.000634	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL6—ovarian cancer	0.000117	0.000631	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000116	0.000629	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000116	0.000629	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCND1—ovarian cancer	0.000114	0.000618	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CTNNB1—ovarian cancer	0.000113	0.000612	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MMP9—ovarian cancer	0.000111	0.0006	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CG—ovarian cancer	0.000111	0.000599	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PTEN—ovarian cancer	0.00011	0.000596	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.00011	0.000595	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—YAP1—ovarian cancer	0.000109	0.00059	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—FASN—ovarian cancer	0.000109	0.00059	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000108	0.000584	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—AKT1—ovarian cancer	0.000108	0.000582	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—SLC5A5—ovarian cancer	0.000107	0.00058	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000105	0.000567	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—SLC2A1—ovarian cancer	0.000104	0.00056	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000102	0.000548	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NME2—ovarian cancer	0.0001	0.000541	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—VEGFA—ovarian cancer	9.97e-05	0.000539	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CYP1B1—ovarian cancer	9.94e-05	0.000537	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—STAT3—ovarian cancer	9.87e-05	0.000533	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NRAS—ovarian cancer	9.85e-05	0.000532	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYTB—ovarian cancer	9.79e-05	0.000529	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CD—ovarian cancer	9.75e-05	0.000527	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	9.56e-05	0.000517	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.49e-05	0.000513	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MAPK3—ovarian cancer	9.43e-05	0.00051	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CA—ovarian cancer	9.31e-05	0.000503	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MYC—ovarian cancer	9.17e-05	0.000496	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MAPK1—ovarian cancer	8.98e-05	0.000485	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—EGFR—ovarian cancer	8.97e-05	0.000485	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	8.97e-05	0.000485	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—FASN—ovarian cancer	8.9e-05	0.000481	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PPP2R1A—ovarian cancer	8.81e-05	0.000476	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.77e-05	0.000474	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—SLC5A5—ovarian cancer	8.75e-05	0.000473	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PPP1CC—ovarian cancer	8.55e-05	0.000462	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—BRIP1—ovarian cancer	8.55e-05	0.000462	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CB—ovarian cancer	8.5e-05	0.000459	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—KRAS—ovarian cancer	8.48e-05	0.000458	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—SLC2A1—ovarian cancer	8.45e-05	0.000457	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYTB—ovarian cancer	8.36e-05	0.000452	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.28e-05	0.000447	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ABCB1—ovarian cancer	8.18e-05	0.000442	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.17e-05	0.000442	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYP1B1—ovarian cancer	8.1e-05	0.000438	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—TYMS—ovarian cancer	8.04e-05	0.000434	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CA—ovarian cancer	7.79e-05	0.000421	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—AKT1—ovarian cancer	7.61e-05	0.000411	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TP53—ovarian cancer	7.53e-05	0.000407	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTEN—ovarian cancer	7.34e-05	0.000397	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PPP1CC—ovarian cancer	7.31e-05	0.000395	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—BRIP1—ovarian cancer	7.31e-05	0.000395	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—HRAS—ovarian cancer	7.21e-05	0.000389	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PPP2R1A—ovarian cancer	7.19e-05	0.000388	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.15e-05	0.000386	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL6—ovarian cancer	6.9e-05	0.000373	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ABCB1—ovarian cancer	6.67e-05	0.00036	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—TYMS—ovarian cancer	6.55e-05	0.000354	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CAV1—ovarian cancer	6.48e-05	0.00035	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYTB—ovarian cancer	6.45e-05	0.000349	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AKT1—ovarian cancer	6.36e-05	0.000344	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.23e-05	0.000337	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.19e-05	0.000334	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CG—ovarian cancer	5.9e-05	0.000319	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—YAP1—ovarian cancer	5.74e-05	0.00031	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.68e-05	0.000307	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5.64e-05	0.000305	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—BRIP1—ovarian cancer	5.64e-05	0.000305	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.33e-05	0.000288	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CAV1—ovarian cancer	5.28e-05	0.000285	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CD—ovarian cancer	5.19e-05	0.00028	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CA—ovarian cancer	5.18e-05	0.00028	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.04e-05	0.000273	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.99e-05	0.00027	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—YAP1—ovarian cancer	4.9e-05	0.000265	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.85e-05	0.000262	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CG—ovarian cancer	4.81e-05	0.00026	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—FASN—ovarian cancer	4.68e-05	0.000253	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SLC5A5—ovarian cancer	4.6e-05	0.000249	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CB—ovarian cancer	4.52e-05	0.000244	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SLC2A1—ovarian cancer	4.44e-05	0.00024	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.35e-05	0.000235	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.26e-05	0.00023	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP1B1—ovarian cancer	4.26e-05	0.00023	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—AKT1—ovarian cancer	4.23e-05	0.000229	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CD—ovarian cancer	4.23e-05	0.000228	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—FASN—ovarian cancer	4e-05	0.000216	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SLC5A5—ovarian cancer	3.93e-05	0.000212	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTEN—ovarian cancer	3.91e-05	0.000211	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SLC2A1—ovarian cancer	3.8e-05	0.000205	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—YAP1—ovarian cancer	3.78e-05	0.000204	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	3.78e-05	0.000204	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.76e-05	0.000203	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.72e-05	0.000201	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CB—ovarian cancer	3.69e-05	0.000199	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP1B1—ovarian cancer	3.64e-05	0.000197	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ABCB1—ovarian cancer	3.51e-05	0.00019	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—TYMS—ovarian cancer	3.44e-05	0.000186	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	3.23e-05	0.000174	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.21e-05	0.000174	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTEN—ovarian cancer	3.18e-05	0.000172	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—FASN—ovarian cancer	3.08e-05	0.000167	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.03e-05	0.000164	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCB1—ovarian cancer	3e-05	0.000162	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—TYMS—ovarian cancer	2.94e-05	0.000159	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.93e-05	0.000158	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.81e-05	0.000152	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CAV1—ovarian cancer	2.78e-05	0.00015	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CA—ovarian cancer	2.76e-05	0.000149	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.65e-05	0.000143	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.53e-05	0.000137	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.49e-05	0.000135	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CAV1—ovarian cancer	2.37e-05	0.000128	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.31e-05	0.000125	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—TYMS—ovarian cancer	2.27e-05	0.000123	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.27e-05	0.000122	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—AKT1—ovarian cancer	2.25e-05	0.000122	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CA—ovarian cancer	2.25e-05	0.000121	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.22e-05	0.00012	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.16e-05	0.000117	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.94e-05	0.000105	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.9e-05	0.000103	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—AKT1—ovarian cancer	1.84e-05	9.92e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CAV1—ovarian cancer	1.83e-05	9.89e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTEN—ovarian cancer	1.67e-05	9.05e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.67e-05	9.01e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.66e-05	8.95e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.47e-05	7.92e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTEN—ovarian cancer	1.43e-05	7.73e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.28e-05	6.9e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.18e-05	6.38e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTEN—ovarian cancer	1.1e-05	5.97e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.01e-05	5.45e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AKT1—ovarian cancer	9.65e-06	5.21e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AKT1—ovarian cancer	8.24e-06	4.45e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CA—ovarian cancer	7.79e-06	4.21e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AKT1—ovarian cancer	6.36e-06	3.44e-05	CbGpPWpGaD
